# US 2024/0042101 A1 · Photopatterned biomolecule immobilization to guide 3d cell fate in natural protein-based hydrogels

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0042101 A1
- Document ID: US20240042101A1
- Status: Published application
- Kind: A1
- Application number: 18/258,735
- Filed: 2021-12-20
- Published: 2024-02-08
- Earliest claimed: 2020-12-21
- Assignees: University of Washington
- Applicants: University of Washington
- Inventors: Cole DeForest; Ivan Batalov; Kelly Rose Stevens
- Web page: https://patentgrep.com/patent/US20240042101A1

## CPC

- A61L 27/52: Hydrogels or hydrocolloids
- C07D 207/452: with hydrocarbon radicals, substituted by hetero atoms, directly attached to the ring nitrogen atom
- A61L 27/50: Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials}
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- C07C 265/04: of a saturated carbon skeleton
- C07C 331/20: of a saturated carbon skeleton
- C07D 207/46: with hetero atoms directly attached to the ring nitrogen atom
- C07D 403/12: linked by a chain containing hetero atoms as chain links
- C07D 405/12: linked by a chain containing hetero atoms as chain links
- C07F 15/0053: {without a metal-carbon linkage}
- C12N 5/0068: {General culture methods using substrates (for specific animal cell type C12N5/06)}
- A61L 2300/252: Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
- A61L 2300/60: characterised by a special physical form
- C12N 2537/10: Cross-linking
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07F: ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins C07D487/22)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

Materials, methods, and systems for biorthogonal ligation of hydrogel labels to crosslinked-natural polymer hydrogels are provided. A heterobifunctional linker includes a peptide-reactive activated functional group on the heterobifunctional linker, including an activated amine-reactive functional group, an activated thiol-reactive functional group and being reactive with a hydrogel comprising a crosslinked natural polymer. The heterobifunctional linker also includes a photocaged reactive group including a photocaged hydroxylamine, a photocaged alkoxyamine, a photocaged hydrazide, a photocaged amine, a photocaged tetrazine, or a photocaged alkyne-containing moiety. The peptide-reactive activated functional group does not include an azide.

## Claims

### Claim 1

A heterobifunctional linker, comprising:
a peptide-reactive activated functional group on the heterobifunctional linker, comprising an activated amine-reactive functional group, an activated thiol-reactive functional group, or any combination thereof, wherein the peptide-reactive activated functional group is reactive with a hydrogel comprising a crosslinked natural polymer, and
a photocaged reactive group on the heterobifunctional linker, comprising a photocaged hydroxylamine, a photocaged alkoxyamine, a photocaged hydrazide, a photocaged amine, a photocaged tetrazine, or a photocaged alkyne-containing moiety,
wherein the peptide-reactive activated functional group does not comprise an azide.

### Claim 2 (depends on 1)

The heterobifunctional linker of claim 1, wherein the peptide-reactive activated functional group comprises a N-hydroxysuccinimidide (NHS) activated amine-reactive functional group (e.g., an NHS ester), a N-hydroxysulfosuccinimido (NHSS) activated amine-reactive functional group (e.g., a NHSS ester), an isocyanate, an isothiocyanate, or a maleimide-activated thiol-reactive functional group.

### Claim 3 (depends on 1)

The heterobifunctional linker of claim 1, wherein the photocaged reactive group is adapted to be uncaged to provide the reactive group, following exposure to electromagnetic radiation having a predetermined wavelength to provide a reactive hydroxylamine, an alkoxyamine, a reactive hydrazide, a reactive amine, a reactive tetrazine, or a reactive alkyne.

### Claim 4 (depends on 1)

The heterobifunctional linker of claim 1, wherein the photocaged reactive group comprises a reactive group caged with an optionally substituted 2-(2-nitrophenyl) propoxycarbonyl moiety, an optionally substituted nitrobenzyl moiety, an optionally substituted coumarin moiety, an optionally substituted boron-dipyrromethene (BODIPY) moiety, or an optionally substituted ruthenium complex.

### Claim 5

A heterobifunctional linker, having a structure:
wherein R1 is selected from a group consisting of an optionally substituted 2-(2-nitrophenyl) propoxycarbonyl moiety, an optionally substituted nitrobenzyl moiety, an optionally substituted coumarin moiety, an optionally substituted boron-dipyrromethene (BODIPY) moiety, and an optionally substituted ruthenium complex;
wherein R2 is selected from a group consisting of hydrogen, an alkane, an alkyl, and an alcohol; and
wherein R3 is selected from a group consisting of a N-hydroxysuccinimidide (NHS) activated amine-reactive functional group (e.g., an NHS ester), a N-hydroxysulfosuccinimido (NHSS) activated amine-reactive functional group (e.g., a NHSS ester), an isocyanate, an isothiocyanate, or a maleimide-activated thiol-reactive functional group.

### Claim 6 (depends on 5)

The heterobifunctional linker of claim 5, wherein R1 has a structure:
wherein “L” represents the binding position for the structure of claim 5;
wherein R4-R9 are independently selected from a group consisting of methyl, methoxy, carboxylic acid, ethyl, ethoxy, alkyl, aryl, —OH, —OR, —OC6H5, —NH2, —NR2, —NHCOCH3, —CH2Cl, —F, —Cl, —Br, —I, —CH═CHNO2, —NO3, —NH3+, —PR3+, —SR2, —IC6H5, —CF3, —CCl3, —SO3H, —SO2R, —CO2H, —CO2R, —CONH2, —CHO, —COR, and —CN; and
wherein the combination of substitutions at R4-R9 determines a wavelength of electromagnetic radiation at which R1 is removed from the structure of claim 5.

### Claim 7 (depends on 5)

The heterobifunctional linker of claim 5, wherein R3 has a structure:
wherein “L” represents the binding position for the structure of claim 5.

### Claim 8 (depends on 5)

The heterobifunctional linker of claim 5, having the structure:

### Claim 9 (depends on 5)

The heterobifunctional linker of claim 5, having the structure:

### Claim 10 (depends on 5)

The heterobifunctional linker of claim 5, having the structure:

### Claim 11 (depends on 5)

The heterobifunctional linker of claim 5, having the structure:

### Claim 12 (depends on 5)

The heterobifunctional linker of claim 5, having the structure:

### Claim 13 (depends on 5)

The heterobifunctional linker of claim 5, having the structure:

### Claim 14 (depends on 5)

The heterobifunctional linker of claim 5, having the structure:

### Claim 15 (depends on 5)

The heterobifunctional linker of claim 5, having the structure:
wherein R10 and R11 are independently selected from a group consisting of hydrogen, alkane, alkyl, carboxyl, or the like.

### Claim 16 (depends on 5)

The heterobifunctional linker of claim 5, having the structure:
Wherein R12 is selected from a group consisting of Hydrogen, an alkane, an alkyl, an alcohol, an alkyne, and a methyl.

### Claim 17 (depends on 16)

The heterobifunctional linker of claim 16, having the structure:

### Claim 18 (depends on 16)

The heterobifunctional linker of claim 16, having the structure:

### Claim 19

A hydrogel, comprising:
a hydrogel matrix comprising a crosslinked natural polymer; and
a covalently linked hydrogel label at predetermined locations in the hydrogel matrix, wherein the hydrogel label is covalently linked to the hydrogel via a linker.

### Claim at position 20

20-38. (canceled)
